Global X Robo Global Robotics & Automation ETF vs Recursion Pharmaceuticals Inc — how do they compare? Global X Robo Global Robotics & Automation ETF trades at $79.51, while Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B). The key difference: Global X Robo Global Robotics & Automation ETF is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| ROBO | RXRX | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $90.34 | $6.79 |
52-Week Low | $61.34 | $2.84 |
Market Cap | — | $1.53B |
Enterprise Value | — | $946.50M |
Trailing returns across standard periods
ROBO is a thematic ETF that tracks the global robotics and automation industry. It provides diversified exposure to companies leading in industrial robotics, 3D printing, and surgical systems, with holdings like Intuitive Surgical and Zebra Technologies.
Read more on ROBO →Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →